VxP Pharma Expands Commercial Service Offering

VxP Pharma Services announced today an expansion of their service offering to include process development and commercial manufacturing for multiple pharmaceutical and biotech dosage forms. This expansion includes oral solids and oral liquids, sterile products, transdermal, topical, as well as many highly specialized dosage forms.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

VxPPharma.com

VxP Pharma has been experiencing rapid growth, and we feel that our continued expansion into commercial services is a natural extension of our business model.

(PRWEB) July 24, 2014

Indianapolis* VxP Pharma Services announced today an expansion of their service offering to include process development and commercial manufacturing for multiple dosage forms. Commercially available dosage forms offered by VxP now include:

  •     Oral Solids and Oral Liquids
  •     Sterile Liquids and Sterile Powders
  •     Ophthalmic Products
  •     Topicals
  •     Transdermal Patches
  •     Animal Health Products
  •     Effervescent tablets, sachets, and other highly specialized dosage forms

VxP Pharma CEO - Raymond E. Peck says, “Although the majority of our business at VxP involves small and large molecule development programs for clinical trials, we have had an increasing number of requests for commercial scale development and production. In order to respond to this increase in demand, we have expanded our commercial services capacity for both the pharmaceutical and biotech industries.”

All of the cGMP development and manufacturing facilities of VxP Pharma are based in the United States, and all have been audited and approved by the US-FDA, as well as numerous international regulatory bodies.

VxP Pharma operates as a full service CRO/CMO offering drug development and manufacturing services, including commercial scale production, to the pharmaceutical and biotech industries. VxP is headquartered in Indianapolis, Indiana. To find out more, please visit: http://www.vxppharma.com .

Press Release Contact Information:
Lisa Fay
Chief Operations Officer
VxP Pharma Services, Inc.
317-759-2299
Lisa.Fay(at)VxPPharma(dot)com


Contact